
Gyun Min Lee, PhD
Professor, Cell and Developmental Biology, KAIST, Korea

Arun Alphonse Ignatius, PhD
Director, Drug Product Sciences, Macrogenics, Inc., USA

Richard D. Braatz, PhD
Edwin R. Gilliland Professor, Chemical Engineering, Massachusetts Institute of Technology

Yves Durocher, PhD
Research Officer & Head, Mammalian Cell Expression, National Research Council Canada

Vered Caplan
CEO, Orgenesis, Inc.

James Reilly
Associate Director, Regeneron Pharmaceuticals Inc.

Ayda S. Mayer, PhD
Executive Director, Vector Core, REGENXBIO, Inc

Florence Salmon, PhD
Vice President, Regulatory Affairs and Preclinical Development, Ridgeline Discovery

Dan Bach Kristensen, PhD
Principal Scientist, Symphogen, Denmark

James Warren, PhD
Vice President, Pharmaceutical Development, Ultragenyx Pharmaceutical